Navigation Links
U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
Date:10/5/2009

FRAMINGHAM, Mass. and SYDNEY, Oct. 5 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the number of clinical sites participating in its U.S. bridge-to-transplant trial, known as the ADVANCE trial. Pursuant to the FDA approval, HeartWare will be permitted to enroll a total of 40 clinical sites for the purposes of evaluating the Company's Ventricular Assist System (HVAD) in end-stage heart failure patients requiring circulatory support to bridge them to a heart transplant.

"We continue to be encouraged by the number of physicians who believe the HVAD may provide an important benefit for their patients and we hope that the enthusiasm for our system continues to grow as their experience expands," said Doug Godshall, President and CEO of HeartWare.

"While we have had strong interest from high caliber transplant centers that want to join our ADVANCE trial, we could not previously accommodate them due to our existing 28 clinical site limitation. Receipt of FDA approval enabling expansion from 28 to 40 clinical sites allows us to accept many of these additional sites prior to the completion of enrolment which we project will occur in the first half of 2010," continued Godshall.

At present, HeartWare currently has 22 clinical sites initiated in the United Sites with 69 patients implanted in the 150 patient study.

About End Stage Heart Failure

Heart failure is one of the leading causes of death in the developed world. According to the American Heart Association, congestive heart failure (CHF) afflicts approximately 5 million people in the U.S. with approximately 550,000 new cases diagnosed each year. Despite new treatment strategies for patients with end-stage heart failure, the number of patients who die with this disease is of epidemic proportion. Cardia
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
3. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
4. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
5. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
6. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
7. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
8. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
9. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... WESTLAKE VILLAGE, Calif. , July 27, 2015 ... KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today announced ... early termination of the waiting period under the Hart-Scott-Rodino ... to Allergan,s pending acquisition of KYTHERA.  ... 6, 2015, each of Allergan and KYTHERA filed a ...
(Date:7/27/2015)... , July 20, 2015 ... addition of the "Global Pressure Relief Devices Market ... Global Pressure Relief Devices market to grow at a ... report, Global Pressure Relief Devices Market 2015-2019, has been ... from industry experts. The report covers the Americas, and ...
(Date:7/27/2015)... , July 27, 2015  Attorney Advertising-- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  Such investors are advised to contact ... coordinator Eitan Kimelman at info@bgandg.com ... whether AMAG and certain of its officers and/or ...
Breaking Medicine Technology:Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals Inc. 2
... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWAD ... financial results for the second quarter ended June 30th, ... 2010, the Company,s quarterly net sales increased 106% to ... period in 2009, driven by growth in prescription and ...
... CORAL SPRINGS, Fla., Aug. 17 VirtuOx, Inc., ... in delivering home sleep testing solutions, today announced ... products and services company currently servicing the sleep-disordered ... in its portfolio, the VirtuOx Home Sleep Test ...
Cached Medicine Technology:HealthWarehouse.com Reports 106% Revenue Growth in the Second Quarter 2010 Compared to 2009 2VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions 2VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions 3
(Date:7/27/2015)... ... ... Dr. Robert G. Schwartz , principal of Greenville, SC-based Piedmont Physical ... Centers in order to offer his patients a new system of care utilizing laser ... , Peripheral neuropathy is a disease caused by damage to the peripheral nerves, and ...
(Date:7/27/2015)... , ... July 28, 2015 , ... Combination Product GMP ... – 3:00 p.m. EDT, http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug ... of combination products things can get messy in a hurry. In a 46-page draft ...
(Date:7/27/2015)... ... July 28, 2015 , ... Recently, the Anderson ... medicine provider for the entire school district including Anderson County Middle School (ACMS) ... Rick Sallee, “Student safety and well-being are a top priority for us in ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional Women ... VIP Woman of the Year Circle. She is recognized with this prestigious distinction for ... NAPW is the nation’s leading networking organization exclusively for professional women. , “I’m pleased ...
(Date:7/27/2015)... Garden City, NY (PRWEB) , ... July 28, 2015 , ... ... as a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. ... 700,000 members and over 200 operating Local Chapters, NAPW is the nation’s leading networking ...
Breaking Medicine News(10 mins):Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:KORT Physical Therapy Named Sports Medicine Provider for Anderson County School System 2Health News:KORT Physical Therapy Named Sports Medicine Provider for Anderson County School System 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2
... Contest ... ... -- InSound Medical , manufacturer and developer of Lyric®, the first 100 percent invisible, ... Lyric Hearing Story" Contest. Lyric wearers have the opportunity to win a free year ...
... , SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ ... announced that its board of directors has declared a third quarter 2009 ... equivalent to an annualized dividend of $0.44 per common share. , ... has declared a dividend of $0.46094 per share of the company,s 7.375% ...
... , THOUSAND OAKS, Calif., Sept. 15 ... the Court of Appeals for the Federal Circuit affirmed the ... four Amgen patents (,868, ,698, ,933 and ,422) relating to ... a fifth patent (,349), the Federal Circuit reversed the holding ...
... Approval Provides Important Tool to Fight Pandemic , , ... announced today that it has approved four vaccines against the 2009 H1N1 ... become available, which is expected within the next four weeks. , ... , , "Today,s approval is good news for our ...
... big reason why, researchers say , TUESDAY, Sept. 15 ... the hospital are much less likely to survive than white ... appears to result from the hospital in which black patients ... the researchers said. , "We know that survival after having ...
... , WASHINGTON, Sept. 15 The American ... impact on health care issues conducted by Pulse Opinion Research, LLC, ... of Americans believe that high immigration levels have had an adverse ... Republicans (89%) felt more strongly on the issue, but Democrats ...
Cached Medicine News:Health News:InSound Medical Kicks Off "Tell Us Your Story" Contest 2Health News:BioMed Realty Trust Declares Third Quarter 2009 Common Stock and Preferred Stock Dividends 2Health News:Appeals Court Affirms Patent Infringement Rulings Against Roche's peg-EPO Product 2Health News:FDA Approves Vaccines for 2009 H1N1 Influenza Virus 2Health News:FDA Approves Vaccines for 2009 H1N1 Influenza Virus 3Health News:Blacks Fare Worse After Cardiac Arrest 2Health News:Blacks Fare Worse After Cardiac Arrest 3Health News:National Poll Finds Most Americans Believe Immigration Adversely Affects the Quality and Cost of Healthcare 2
... kit is an enzymeimmunoassay for the quantitation ... in serum or plasma. Calibrators, controls and ... D. The diluted samples are incubated in ... highly specific sheep 25-OH D antibody for ...
... responsible for the control of glucose metabolism. ... islets of Langerhans as the precursor, proinsulin, which ... Both are secreted in equimolar amounts into the ... comprised of two polypeptide chains, the A-chain and ...
... Angiotensin Converting Enzyme (ACE) is an integral ... the generation of Angiotensin II as well ... many different cell types, ACE is primarily ... only an important diagnostic parameter for sarcoidosis ...
... (RBP) is small (21kD) transport protein for ... in blood but loses its affinity for,prealbumin ... the target cells. The free,RBP molecule is ... catabolized in the,renal tubules after resorption by ...
Medicine Products: